ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.42
-0.13 (-5.10%)
At close: Aug 18, 2025, 3:59 PM
2.47
1.86%
Pre-market: Aug 19, 2025, 06:07 AM EDT
ImmunityBio Revenue
ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending June 30, 2025, ImmunityBio generated $26.43M in revenue.
Revenue (ttm)
14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
21.97K
Employees
671
Market Cap
2.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14.74M | +2270.58% |
| Dec 31, 2023 | 622K | +159.17% |
| Dec 31, 2022 | 240K | -74.30% |
| Dec 31, 2021 | 934K | +54.38% |
| Dec 31, 2020 | 605K | -72.52% |
| Dec 31, 2019 | 2.2M | +4585.11% |
| Dec 31, 2018 | 47K | +4.44% |
| Dec 31, 2017 | 45K | +2.27% |
| Dec 31, 2016 | 44K | -81.36% |
| Dec 31, 2015 | 236K | -63.18% |
| Dec 31, 2014 | 641K | +6.83% |
| Dec 31, 2013 | 600K | n/a |